DVL1 and breast cancer: Similarly, circ-ITCH, though more extensively studied in other breast cancer subtypes, functions as a tumor suppressor by stabilizing ITCH-mediated ubiquitination of Dvl proteins, thereby inhibiting Wnt/β-catenin activation [41].